Juno Therapeutics junotherapeutics.com


Public list: BIO 2016 (619) Pharma Startups (4731)

Juno Therapeutics (NASDAQ: JUNO) is a clinical-stage company that brings together three of the world's leading cancer centers – Fred Hutchinson Cancer Research Center, Memorial Sloan-Kettering Cancer Center and Seattle Children's Research Institute – in unique partnership to advance a broad pipeline of breakthrough immunotherapies. Juno will build on the foundation of novel immunotherapies to develop two distinct and complementary platforms – CARs and TCRs. The CAR technology is designed t...Show all

Juno Therapeutics (NASDAQ: JUNO) is a clinical-stage company that brings together three of the world's leading cancer centers – Fred Hutchinson Cancer Research Center, Memorial Sloan-Kettering Cancer Center and Seattle Children's Research Institute...Show all

Company (IPO / Went public)

Phone: 206-582-1600

Fax:

307 Westlake Avenue North
Suite 300
Seattle, 98109
Washington, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Juno Therapeutics $574.6M Dec 19, 2014
Kite Pharma $212.8M Oct 3, 2017
Stemcentrx $520M Apr 28, 2016
See all 3 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Juno Therapeutics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 6 investors

Competitors

Company Status Description Investors
See all 3 competitors